"The new dean, Dr. Laurie H. Glimcher, 60, who has ties to the pharmaceutical giants Merck and Bristol-Myers Squibb as well as to scientific and biotechnology companies, said she wanted to use her experience to forge partnerships with both the public and private sectors.
Dr. Glimcher, an immunologist with a strong interest inosteoporosis, defended her outside interests, saying they presented no conflict as long as they were transparent. She said she wanted to “leverage the strengths of everyone,” whether scientists, pharmaceutical companies or biotechnology companies. “There should be no silos between all of these different strengths,” she said."
Nenhum comentário:
Postar um comentário